Why this project qualifies
With $550 million in facility-specific investment and 650 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). This project also meets AFT's primary-source verification and physical U.S. manufacturing-footprint requirements.
View full methodology →Why it matters
The medical devices & diagnostics context.
Medical Devices & Diagnostics tracks qualifying U.S. factories producing medical devices, diagnostic instruments, testing systems, drug-delivery devices, vision-care products, and related regulated healthcare equipment. Pharmaceutical drug production remains in AFT's dedicated Pharmaceuticals category.
Project record
At a glance
- Company
- Roche Group (Roche Diagnostics)
- Industry
- Medical Devices & Diagnostics
- Location
- Indianapolis, Indiana
- Investment
- $550.0M
- Permanent jobs announced
- 650
- Status
- Under Construction
- Announced
- May 12, 2025
- Expected opening
- 2030
- Added to tracker
- Sep 1, 2026
Sources
Official references
- Roche Diagnostics' May 12, 2025 Indianapolis continuous-glucose-monitoring manufacturing announcement https://diagnostics.roche.com/us/en/news-listing/2025/roche-announces-550-million-investment-to-expand-its-indianapolis-diagnostics-manufacturing-hub.html
- Indianapolis municipal incentive materials itemizing the CGM expansion https://mccmeetingspublic.blob.core.usgovcloudapi.net/indymarion-meet-deb46adbccea4892ab07abaf19f78ec9/ITEM-Attachment-001-2cdf8f42939a4b2a9f019a784bf8fc7f.pdf
- The Republic's July 2026 report of first-phase Indianapolis renovation and 2027 production target https://www.therepublic.com/2026/07/11/roche-diagnostics-expanding-indy-campus-to-focus-on-diabetes-care/
Related
Other projects to know
In Indiana
Back to the tracker/projects/roche-diagnostics-indianapolis-cgm-manufacturing-hub